US 7741304
Casein kinase 2 antisense therapy
granted A61KA61K48/0008A61P
Quick answer
US patent 7741304 (Casein kinase 2 antisense therapy) held by Regents of the University of Minnesota expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Jun 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K48/0008, A61P, A61P35/00